ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | 0.0% | 469 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $5,000 | +25.0% | 469 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $4,000 | -42.9% | 469 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | -41.7% | 469 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $12,000 | +20.0% | 469 | +17.2% | 0.01% | +25.0% |
| Q2 2021 | $10,000 | -28.6% | 400 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $14,000 | +40.0% | 400 | 0.0% | 0.01% | +20.0% |
| Q4 2020 | $10,000 | -33.3% | 400 | 0.0% | 0.01% | -44.4% |
| Q3 2020 | $15,000 | -11.8% | 400 | 0.0% | 0.01% | -18.2% |
| Q2 2020 | $17,000 | +112.5% | 400 | 0.0% | 0.01% | +83.3% |
| Q1 2020 | $8,000 | -20.0% | 400 | 0.0% | 0.01% | +20.0% |
| Q4 2019 | $10,000 | -9.1% | 400 | 0.0% | 0.01% | -16.7% |
| Q3 2019 | $11,000 | 0.0% | 400 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $11,000 | -8.3% | 400 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $12,000 | +9.1% | 400 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $11,000 | – | 400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |